AR035550A1 - Composiciones estables biocidas - Google Patents
Composiciones estables biocidasInfo
- Publication number
- AR035550A1 AR035550A1 ARP000102753A ARP000102753A AR035550A1 AR 035550 A1 AR035550 A1 AR 035550A1 AR P000102753 A ARP000102753 A AR P000102753A AR P000102753 A ARP000102753 A AR P000102753A AR 035550 A1 AR035550 A1 AR 035550A1
- Authority
- AR
- Argentina
- Prior art keywords
- liquid phase
- active ingredient
- biocide
- composition
- biocid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Dermatology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composición particionada (preferiblemente biocida) que comprende, en una primera fase líquida (preferentemente orgánica) un primer ingrediente activo (preferiblemente biocida), y, en una segunda fase líquida(preferiblemente acuosa) con un pH, un segundo ingrediente activo (preferiblemente biocida), dicho ingrediente activo en dicha primera fase líquida resulta químicamente inestable en las condiciones de dicha segunda fase líquida. Opcionalmente las partículas podrían ser suspendidas en al menos la fase acuosa preferida y preferiblemente dichas partículas son biocidas en sí mismas. La composición permite una composición antelmíntica físicamente y químicamente estable a ser preparada de al menos tres ingredientes activos antelmínticos, viz un antibiótico ML (por ejemplo ivermectina), levamisola y una benzimidazola (por ejemplo albendazola).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ33613999A NZ336139A (en) | 1999-06-04 | 1999-06-04 | Pesticidal emulsion composition containing levamisole in the aqueous phase and an anthelmintic in the organic phase |
NZ33621399 | 1999-06-10 | ||
NZ33681499 | 1999-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR035550A1 true AR035550A1 (es) | 2004-06-16 |
Family
ID=27353893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102753A AR035550A1 (es) | 1999-06-04 | 2000-06-02 | Composiciones estables biocidas |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1182931B1 (es) |
AR (1) | AR035550A1 (es) |
AT (1) | ATE313952T1 (es) |
AU (2) | AU772988B2 (es) |
DE (1) | DE60025198D1 (es) |
WO (1) | WO2000074489A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ520295A (en) * | 2002-07-19 | 2005-04-29 | Ashmont Holdings Ltd | Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin |
AU2002952597A0 (en) * | 2002-11-11 | 2002-11-28 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
NZ523128A (en) * | 2002-12-12 | 2006-01-27 | Ashmont Holdings Ltd | Anthelmintic formulations containing avermectins and or milbemycins |
NZ529177A (en) * | 2003-10-24 | 2005-12-23 | Agres Ltd | Administration process for a delivery device that releases the active agent over several days |
US7671034B2 (en) * | 2003-12-19 | 2010-03-02 | Merial Limited | Stabilized formulation of ivermectin feed premix with an extended shelf life |
PT1713468E (pt) * | 2004-02-03 | 2010-06-18 | Wyeth Llc | Composição anti-helmíntica |
AR056808A1 (es) * | 2005-11-18 | 2007-10-24 | Cheminova As | Formulacion de aceite en agua de avermectinas |
PT1957040E (pt) * | 2005-12-06 | 2015-01-14 | Zoetis W Llc | Composições não aquosas de benzimidazol |
BRPI0506279B1 (pt) | 2005-12-16 | 2018-01-09 | Npa - Núcleo De Pesquisas Aplicadas Ltda | Composição sinergística de antihelmínticos e endectocidas |
FR2900052B1 (fr) | 2006-04-19 | 2011-02-18 | Galderma Sa | Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine |
NZ550279A (en) * | 2006-09-29 | 2008-01-31 | Bomac Research Ltd | Medicament |
FR2907012B1 (fr) * | 2006-10-12 | 2012-09-21 | Galderma Sa | Composition dermatologique comprenant des nanocapsules d'avermectine, son procede de preparation et son utilisation |
NZ552293A (en) * | 2006-12-21 | 2009-03-31 | Bomac Research Ltd | Tablet formulation comprising a macrocyclic lactone and a levamisole compound having anthelmintic activity |
AU2014201152C1 (en) * | 2006-12-21 | 2017-01-12 | Bayer New Zealand Limited | Tablet Formulation |
AU2008360070B2 (en) * | 2008-07-29 | 2015-04-30 | Bomac Research Limited | Tablet manufacturing method |
EP2362774A1 (en) * | 2008-08-18 | 2011-09-07 | Intervet International BV | Anthelmintic compositions |
WO2010042395A1 (en) | 2008-10-08 | 2010-04-15 | Wyeth Llc | Benzimidazole anthelmintic compositions |
CA3040719C (en) * | 2009-09-07 | 2022-06-14 | Argenta Innovation Limited | Granulated anthelmintic preparations and delivery systems |
US20120196821A1 (en) * | 2009-10-19 | 2012-08-02 | Roger Mervyn Sargent | Method and formulation for the control of parasites |
BRPI0904365A2 (pt) * | 2009-11-05 | 2011-11-16 | Ouro Fino Participacoes E Empreendimentos S A | associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais |
UA108641C2 (uk) | 2010-04-02 | 2015-05-25 | Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування | |
WO2011143479A1 (en) * | 2010-05-12 | 2011-11-17 | Merial Limited | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
AU2016201743B2 (en) * | 2010-05-12 | 2017-10-19 | Boehringer Ingelheim Animal Health USA Inc. | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
AR081970A1 (es) | 2010-06-24 | 2012-10-31 | Intervet Int Bv | Formulacion inyectable de una lactona macrociclica y levamisol, formulacion y uso veterinario |
AU2010101389C4 (en) * | 2010-12-08 | 2017-03-02 | Jurox Pty Ltd | Anthelmintic formulation |
CA2839491A1 (en) | 2011-06-23 | 2012-12-27 | Bayer New Zealand Limited | Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation |
NZ594610A (en) | 2011-08-16 | 2013-03-28 | Virbac New Zealand Ltd | Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants |
WO2013043064A1 (en) * | 2011-09-23 | 2013-03-28 | Alleva Animal Health Limited | Veterinary anthelmintic delivery system |
AU2013257335B2 (en) * | 2012-05-01 | 2017-03-02 | Nexan Corporation Limited | Anthelmintic compositions |
AU2016200283B2 (en) * | 2015-02-21 | 2016-10-13 | Al Hanbali, Othman Abdul Rahim DR | LEVIA: A New Injectable Parasiticidal Veterinary Formulation of Levamisole HCI and Ivermectin Solution |
WO2018038623A1 (en) * | 2016-08-23 | 2018-03-01 | Donaghys Limited | Improvements in parasite treatments |
EP3749096A1 (en) | 2018-02-08 | 2020-12-16 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof |
WO2020150032A1 (en) | 2019-01-16 | 2020-07-23 | Boehringer Ingelheim Animal Health USA Inc. | Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof |
US11253533B1 (en) * | 2020-11-10 | 2022-02-22 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL180633C (nl) * | 1973-06-22 | 1900-01-01 | Bayer Ag | Werkwijze ter bereiding van een anthelmintisch werkzaam veterinair opgiet-preparaat. |
JPS521046A (en) * | 1975-06-24 | 1977-01-06 | Oshio Sangyo Kk | Sterile packing method of foods |
US4278684A (en) * | 1980-06-17 | 1981-07-14 | Janssen Pharmaceutica N.V. | Non-toxic anthelminthic pour-on composition |
CA1194791A (en) * | 1981-05-08 | 1985-10-08 | John M. Ballany | Parasiticidal pour-on compositions |
JPS5821615A (ja) * | 1981-07-29 | 1983-02-08 | Fujisawa Pharmaceut Co Ltd | 草食獣の肝蛭症の予防治療剤 |
JPS5820622A (ja) * | 1982-06-11 | 1983-02-07 | 押尾産業株式会社 | 食品等の包装方法 |
ZA842571B (en) * | 1983-04-07 | 1985-11-27 | Merck & Co Inc | Novel synergistic antiparasitic combinations |
GB8515459D0 (en) * | 1985-06-19 | 1985-07-24 | Young Robert Co Ltd | Parasitical compositions |
FR2584927B1 (fr) * | 1985-07-17 | 1988-09-23 | Elf Aquitaine | Composition liquide, stable, anthelminthique et fongicide a base de bithionol sulfoxyde |
IL80767A0 (en) * | 1985-11-27 | 1987-02-27 | Syntex Inc | Amorphous benzimidazole derivatives,their preparation and anthelmintic compositions containing them |
JPH04220398A (ja) * | 1990-12-21 | 1992-08-11 | Fuji Photo Film Co Ltd | 平版印刷用湿し水組成物及び平版印刷方法 |
JPH0717812A (ja) * | 1993-07-05 | 1995-01-20 | Shinto Paint Co Ltd | 工業用防カビ組成物 |
CN1069032C (zh) * | 1997-03-27 | 2001-08-01 | 中国农业大学 | 一种含阿维菌素/依维菌素的兽用抗寄生虫药 |
-
2000
- 2000-06-02 WO PCT/NZ2000/000087 patent/WO2000074489A1/en active IP Right Grant
- 2000-06-02 AU AU49595/00A patent/AU772988B2/en not_active Expired
- 2000-06-02 EP EP00931765A patent/EP1182931B1/en not_active Expired - Lifetime
- 2000-06-02 AR ARP000102753A patent/AR035550A1/es not_active Application Discontinuation
- 2000-06-02 AT AT00931765T patent/ATE313952T1/de not_active IP Right Cessation
- 2000-06-02 DE DE60025198T patent/DE60025198D1/de not_active Expired - Lifetime
-
2008
- 2008-12-18 AU AU2008260443A patent/AU2008260443A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2008260443A1 (en) | 2009-01-15 |
EP1182931A4 (en) | 2003-01-29 |
AU4959500A (en) | 2000-12-28 |
WO2000074489A1 (en) | 2000-12-14 |
ATE313952T1 (de) | 2006-01-15 |
EP1182931A1 (en) | 2002-03-06 |
EP1182931B1 (en) | 2005-12-28 |
DE60025198D1 (de) | 2006-02-02 |
AU772988B2 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR035550A1 (es) | Composiciones estables biocidas | |
AR030245A1 (es) | Composiciones de gel que contienen metronidazol | |
BR0108437A (pt) | Piridinil-imidazóis | |
DE50211045D1 (de) | Medizinische aerosolformulierungen | |
YU49202A (sh) | Benzazolski derivati i njihova upotreba kao modulatora jnk | |
CY1110264T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν ευαισθητα σε ρη συμπολυμερη τυπου μπλοκ και υδροφοβο φαρμακο | |
NO20074391L (no) | CIS-2,4,5-triaryl-imidazoliner og deres anvendelse som anti-cancer medikamenter | |
EA200702593A1 (ru) | Высококонцентрированные композиции, применимые для борьбы с экто- и эндопаразитами | |
RS49609B (sr) | Stabilizovani antihistaminski sirup | |
SG127738A1 (en) | Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds | |
BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
DE60134245D1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
HUP0102515A2 (hu) | Ciklopeptidek, eljárás előállításukra, hatóanyagként azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
BR0112417A (pt) | Composições farmacêuticas contendo composto dds | |
EP1057484A4 (en) | INHIBITORS OF CELL DEATH | |
BR0213563A (pt) | Formulações pesticidas | |
BR0107770A (pt) | Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas | |
BR0015256A (pt) | Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano | |
BRPI0518395A2 (pt) | inseticidas | |
BR9811557A (pt) | Derivados do 2-)4-aril ou heteroaril-piperazin-1-ilmetil)-1h-indol | |
YU59201A (sh) | Matrica koja se može direktno komprimovati, za kontrolisano oslobadjanje pojedinačnih dnevnih doza klaritromicina | |
AR034370A1 (es) | Una preparacion farmaceutica acuosa de cilostazol para uso parenteral | |
CY1112917T1 (el) | Υγρες στοματικες συνθεσεις | |
BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal | ||
FG | Grant, registration | ||
FD | Application declared void or lapsed, e.g., due to non-payment of fee |